Subscribe to the latest remote jobs:

CRA II - FSP, Romania

🇷🇴 Romania

Management

GCP

CRA II - FSP, Romania

from 🇷🇴 Romania

This may be time for you to join our innovative FSP team as aClinical Research Associate (CRA) in Romaniaand be at the forefront of groundbreaking medical advancements in a variety of indications (Oncology, Neurology, Gene Therapy...).

Key Responsibilities:

  • Monitor Clinical Trials -conduct site visits to ensure compliance with protocols, regulatory requirements and Good Clinical Practice (GCP)
  • Site Management - Serve as the primary point of contact for investigational sites, ensuring smooth study operations.
  • Source Document Verification (SDV)- Review and verify accuracy of clinical data collected from study sites.
  • Investigator Training and Support - Provide ongoing training to site staff on study protocols and regulatory requirements
  • Reporting and Documentation-Prepare monitoring reports, maintain study records, and contribute to overall trial documentation.

​​Qualifications:

  • Life Sciences University degreeorcertification in a related allied health profession from an appropriately accredited institution (e.g., nursing licensure).(Fortrea may consider relevant and equivalent experience in lieu of educational requirements)
  • Thorough understanding ofICH GCP Guidelines and understanding oflocal regulatory requirements.
  • Thoroughknowledge of monitoring procedures and basic understanding of the clinical trial process.
  • Fluency in Romanian and in English, both written and verbal.

What We Offer:

  • Flexible work arrangements (hybrid /remote options)
  • Career growth environment in a supportive environment
  • Dedicated Line Manager
  • Works directly with a leading sponsor on innovative studies
  • Attractive salary and Fortrea benefits

If you are passionate about clinical research, thrive in a collaborative environment, and seek exciting career growth, we want to hear from you!

#LI-Remote#LI-Hybrid

Learn more about ourEEO & Accommodations request here.

by @maxrusakovic